19 related articles for article (PubMed ID: 9309783)
1. Prevalence of HER2 overexpression and amplification in cervical cancer: A systematic review and meta-analysis.
Itkin B; Garcia A; Straminsky S; Adelchanow ED; Pereyra M; Haab GA; Bardach A
PLoS One; 2021; 16(9):e0257976. PubMed ID: 34591928
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Vascular Endothelial Growth Factor (VEGF) and Her-2 Protein in the Genesis of Cervical Carcinoma.
Rahmani AH; Babiker AY; Alsahli MA; Almatroodi SA; Husain NEOS
Open Access Maced J Med Sci; 2018 Feb; 6(2):263-268. PubMed ID: 29531585
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection.
Shukla S; Shishodia G; Mahata S; Hedau S; Pandey A; Bhambhani S; Batra S; Basir SF; Das BC; Bharti AC
Mol Cancer; 2010 Oct; 9():282. PubMed ID: 20977777
[TBL] [Abstract][Full Text] [Related]
4. Distribution of prognostically unfavourable product of c-erbB-2 oncogene and EGF-R in carcinomas of the breast and uterine cervix.
Ray A; Naik SL; Sharma BK
Indian J Physiol Pharmacol; 2002 Oct; 46(4):423-33. PubMed ID: 12683217
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of co-overexpression of bcl-2 and c-erbB-2/neu in uterine cervix carcinomas and premalignant lesions.
Protrka Z; Arsenijević S; Arsenijević P; Mitrović S; Stanković V; Milosavljević M; Nedović J; Kastratović T; Durić J
Med Glas (Zenica); 2012 Aug; 9(2):248-55. PubMed ID: 22926359
[TBL] [Abstract][Full Text] [Related]
6. The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix.
Chang JL; Tsao YP; Liu DW; Han CP; Lee WH; Chen SL
Gynecol Oncol; 1999 Apr; 73(1):62-71. PubMed ID: 10094882
[TBL] [Abstract][Full Text] [Related]
7. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Cancer; 1996 Aug; 78(3):433-40. PubMed ID: 8697388
[TBL] [Abstract][Full Text] [Related]
9. c-erbB-2 oncoprotein and epidermal growth factor receptor in cervical lesions.
Lakshmi S; Nair MB; Jayaprakash PG; Rajalekshmy TN; Nair MK; Pillai MR
Pathobiology; 1997; 65(3):163-8. PubMed ID: 9309783
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of epidermal growth factor receptor].
Penault-Llorca F; Durando X; Bay JO
Bull Cancer; 2003 Nov; 90 Spec No():S192-6. PubMed ID: 14763139
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
